Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization

Maternal Vaccination With a Monocomponent Pertussis Toxoid Vaccine Is Sufficient to Protect Infants in a Baboon Model of Whooping Cough

(2018) Parul Kapil et al.   JOURNAL OF INFECTIOUS DISEASES

Synergistic Neutralization of Pertussis Toxin by a Bispecific AntibodyIn VitroandIn Vivo

(2016) Ellen K. Wagner et al.   Clinical and Vaccine Immunology

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

(2016) Jiwon Lee et al.   NATURE MEDICINE

Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines

(2016) Chun-Ting Yuen et al.   VACCINE

Pertussis vaccines and the challenge of inducing durable immunity

(2015) Jason M Warfel et al.   CURRENT OPINION IN IMMUNOLOGY

Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization

(2015) Anita H J van den Biggelaar et al.   Expert Review of Vaccines

Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing

(2015) Caitlin A. Kowalsky et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A cocktail of humanized anti–pertussis toxin antibodies limits disease in murine and baboon models of whooping cough

(2015) Annalee W. Nguyen et al.   Science Translational Medicine

High-Resolution Sequence-Function Mapping of Full-Length Proteins

(2015) Caitlin A. Kowalsky et al.   PLoS One

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

(2014) Nicole A. Doria-Rose et al.   NATURE

Identification and characterization of the constituent human serum antibodies elicited by vaccination

(2014) Jason J. Lavinder et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination

(2013) Rose-Minke Schure et al.   Clinical and Vaccine Immunology

Perplexities of pertussis: recent global epidemiological trends and their potential causes

(2013) D. W. JACKSON et al.   EPIDEMIOLOGY AND INFECTION

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens

(2013) G.A.M. Berbers et al.   VACCINE

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization

(2011) Jamie N. Sutherland et al.   Clinical and Vaccine Immunology

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure

(2011) J. S. Lavine et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

(2010) T. Dalby et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

(2010) Lotte H. Hendrikx et al.   VACCINE

Characterization of a Key Neutralizing Epitope on Pertussis Toxin Recognized by Monoclonal Antibody 1B7

(2009) Jamie N. Sutherland et al.   BIOCHEMISTRY

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

(2008) Jens Wrammert et al.   NATURE

Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies

(2007) Roxana M. Ionescu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES